Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ...
Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ... Jeffrey Joyce CV 11-8-12 - Kansas City University of Medicine and ...
Jeffrey N. Joyce, Ph.D. December 2012experimental parkinsonism. Synapse 19:46-55, 1995.54. Goldsmith, S. and Joyce, J.N. Alterations in the hippocampal mossy fiber pathway inschizophrenia and Alzheimer’s disease. Biol. Psychiatry 37:122-126, 1995.55. Murray, A.M., Weihmueller, F., Marshall, J.F. Hurtig H.I., Gottleib, G.L. and Joyce, J.N.Damage to dopamine systems differs between Parkinson’s Disease and Alzheimer’s withParkinsonism. Annal. Neurol. 37:300-312, 1995.56. Murray, A.M., Ryoo, H., Gurevich, E. and Joyce, J.N. Localization of dopamine D3receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.Proc. Natl. Acad. Sci. USA 91:11271-11275, 1994.57. Lexow, N., Joyce, J.N., Kim, S.J., Phillips, J., Casanova, M.F., Bird, E.D., Kleinman,J.E.and Winokur, A. Alterations in TRH receptors in temporal lobe of schizophrenics: Aquantitative autoradiographic study. Synapse 18: 315-327, 1994.58. Ulas, J., Weihmuller, F.B., Brunner, L.C., Joyce, J.N., Marshall, J.F., and Cotman, C.W.:Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson’sdiseae, Alzheimer’s disease, and mixed Parkinson’s disease/Alzheimer’s disease patients:an autoradiographic study. J. Neurosci. 14:6317-6324, 1994.59. Ryoo, H and Joyce, J.N. The loss of dopamine D2 receptors varies along the rostrocaudalaxis of the hippocampal complex in Alzheimer’s disease. J. Comp. Neurol. 348:94-110,1994.60. Goldsmith, S. and Joyce, J.N. D2 receptor expression in hippocampus andparahippocampal cortices of human, rat and cat in comparison with tyrosine hydroxylaseimmunoreactive fibers. Hippocampus 4:1-20, 1994.61. Rioux, L., Neal, B.S. and Joyce, J.N. Substance P receptors are differentially altered inParkinson's and Alzheimer's disease. J. Neural Transm.-Parkinson's Dis DementiaSection. 6: 199-210, 1993.62. Neal-Beliveau, B.S. and Joyce, J.N. D1 and D2 dopamine receptors do not up-regulate inresponse to neonatal intrastriatal 6-hydroxydopamine lesions. Neurosci. Lett. 160:77-80,1993.63. Frohna, P.A., Neal-Beliveu, B.S. and Joyce, J.N. Neonatal 6-OHDA lesions upregulateadult expression of tyrosine hydroxylase mRNA. NeuroReport 4: 1095-1098, 1993.64. Neal-Beliveau, B.S., Joyce, J.N., and Lucki, I. Serotonergic involvement in haloperidolinducedcatalepsy. J. Pharmacol. Expt. Therap. 265: 207-217, 1993.65. Joyce, J.N., Kaeger, C, Ryoo, H and Goldsmith, S.: Dopamine D2 receptors in thehippocampus and amygdala in Alzheimer’s disease. Neurosci. Lett..154:171-174, 1993.66. Joyce, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M. F., and Kleinman, J. E.:Serotonin uptake sites and serotonin receptors are altered in limbic system ofschizophrenics. Neuropsychopharmacol. 8:315-336, 1993.67. Joyce, J.N. Differential response of striatal dopamine receptor subtypes and cholinergic14
Jeffrey N. Joyce, Ph.D. December 2012muscarinic receptors to the loss of dopamine: III. Effects in Parkinson’s disease. BrainRes.600:156-160, 1993.68. Murray, A.M., Roo, H., and Joyce, J. Visualization of dopamine D3-like receptors inhuman brain with [ 125 I]epidepride. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227:443-445, 1992.69. Neal, B.S. and Joyce, J.N. Neonatal 6-hydroxydopamine lesions differentially affectstriatal D1 and D2 receptors. Synapse 11:35-46, 1992.70. Joyce, J.N., Lexow, N., Kim, S.J., Artymysh, R., Cassanova, M., Kleinman, J., E. Bird,and A. Winokur.: Distribution of Beta-adrenergic receptor subtypes in human postmortembrain: alterations in limbic regions of schizophrenics. Synapse 10:228-246, 1992.71. Joyce, J.N. Differential response of striatal dopamine receptor subtypes and cholinergicmuscarinic receptors to the loss of dopamine: II. Effects of 6-hydroxydopamine orcolchicine microinjections in the VTA or reserpine treatment. Exp. Neurol. 113:277-290,1991.72. Joyce, J.N. Differential response of striatal dopamine receptor subtypes and cholinergicmuscarinic receptors to the loss of dopamine: I. Effects of intranigral orintracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.Exp. Neurol. 113:261-276, 1991.73. Neal, B.S. and Joyce, J.N. Dopamine D1 receptor behavioral supersensitivity followingselective lesions of the striatal patch compartment during development. Dev. Brain Res.60:105-113, 1991.74. Rao, P., Molinoff, P.B. and Joyce, J.N. Ontogeny of dopamine D1 and D2 receptorsubtypes in rat basal ganglia: a quantitative autoradiographic study. Dev. Brain Res.60:161-177, 1991.75. Joyce, J.N., Janowski, A. and Neve, K.A. Characterization and distribution of[ 125 I]Epidepride binding to dopamine D2 receptors in basal ganglia and cortex of humanbrain. J. Pharmacol. Exp. Ther. 257:1253-1263, 1991.76. Lowenstein, P.R., Joyce, J.N., Coyle, J.T., and Marshall, J.F. Striosomal organization ofcholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adulthuman striatum: A quantitative receptor autoradiographic study. Brain Res.510:122-126,1990.77. Marshall, J.F., Navarrete, R. and Joyce, J.N. Decreased striatal D1 binding densityfollowing mesotelencephalic 6-hydroxydopamine injections: An autoradiographicanalysis. Brain Res. 493: 247-257, 1990.78. Joyce, J.N., Gibbs, R.B., Cotman, C.W. and Marshall, J.F. Regulation of muscarinicreceptors in hippocampus following cholinergic denervation and reinnervation by septaland striatal transplants. J. Neuroscience 9: 2776-2791, 1989.79. Hurtig, H., Joyce, J.N., Sladek, J.R., and Trojanowski, J. Post mortem analysis ofautograft from adrenal medulla to caudate in a patient with Parkinson's disease. Annal.15
- Page 1 and 2: Office AddressVice President, Divis
- Page 3 and 4: Jeffrey N. Joyce, Ph.D. December 20
- Page 5 and 6: Jeffrey N. Joyce, Ph.D. December 20
- Page 7 and 8: Jeffrey N. Joyce, Ph.D. December 20
- Page 9 and 10: Jeffrey N. Joyce, Ph.D. December 20
- Page 11 and 12: Jeffrey N. Joyce, Ph.D. December 20
- Page 13: Jeffrey N. Joyce, Ph.D. December 20
- Page 17 and 18: Jeffrey N. Joyce, Ph.D. December 20
- Page 19 and 20: Jeffrey N. Joyce, Ph.D. December 20
- Page 21 and 22: Jeffrey N. Joyce, Ph.D. December 20
- Page 23 and 24: Jeffrey N. Joyce, Ph.D. December 20
- Page 25 and 26: Jeffrey N. Joyce, Ph.D. December 20
<strong>Jeffrey</strong> N. <strong>Joyce</strong>, Ph.D. December 20<strong>12</strong>experimental parkinsonism. Synapse 19:46-55, 1995.54. Goldsmith, S. <strong>and</strong> <strong>Joyce</strong>, J.N. Alterations in the hippocampal mossy fiber pathway inschizophrenia <strong>and</strong> Alzheimer’s disease. Biol. Psychiatry 37:<strong>12</strong>2-<strong>12</strong>6, 1995.55. Murray, A.M., Weihmueller, F., Marshall, J.F. Hurtig H.I., Gottleib, G.L. <strong>and</strong> <strong>Joyce</strong>, J.N.Damage to dopamine systems differs between Parkinson’s Disease <strong>and</strong> Alzheimer’s withParkinsonism. Annal. Neurol. 37:300-3<strong>12</strong>, 1995.56. Murray, A.M., Ryoo, H., Gurevich, E. <strong>and</strong> <strong>Joyce</strong>, J.N. Localization <strong>of</strong> dopamine D3receptors to mesolimbic <strong>and</strong> D2 receptors to mesostriatal regions <strong>of</strong> human forebrain.Proc. Natl. Acad. Sci. USA 91:<strong>11</strong>271-<strong>11</strong>275, 1994.57. Lexow, N., <strong>Joyce</strong>, J.N., Kim, S.J., Phillips, J., Casanova, M.F., Bird, E.D., Kleinman,J.E.<strong>and</strong> Winokur, A. Alterations in TRH receptors in temporal lobe <strong>of</strong> schizophrenics: Aquantitative autoradiographic study. Synapse 18: 315-327, 1994.58. Ulas, J., Weihmuller, F.B., Brunner, L.C., <strong>Joyce</strong>, J.N., Marshall, J.F., <strong>and</strong> Cotman, C.W.:Selective increase <strong>of</strong> NMDA-sensitive glutamate binding in the striatum <strong>of</strong> Parkinson’sdiseae, Alzheimer’s disease, <strong>and</strong> mixed Parkinson’s disease/Alzheimer’s disease patients:an autoradiographic study. J. Neurosci. 14:6317-6324, 1994.59. Ryoo, H <strong>and</strong> <strong>Joyce</strong>, J.N. The loss <strong>of</strong> dopamine D2 receptors varies along the rostrocaudalaxis <strong>of</strong> the hippocampal complex in Alzheimer’s disease. J. Comp. Neurol. 348:94-<strong>11</strong>0,1994.60. Goldsmith, S. <strong>and</strong> <strong>Joyce</strong>, J.N. D2 receptor expression in hippocampus <strong>and</strong>parahippocampal cortices <strong>of</strong> human, rat <strong>and</strong> cat in comparison with tyrosine hydroxylaseimmunoreactive fibers. Hippocampus 4:1-20, 1994.61. Rioux, L., Neal, B.S. <strong>and</strong> <strong>Joyce</strong>, J.N. Substance P receptors are differentially altered inParkinson's <strong>and</strong> Alzheimer's disease. J. Neural Transm.-Parkinson's Dis DementiaSection. 6: 199-210, 1993.62. Neal-Beliveau, B.S. <strong>and</strong> <strong>Joyce</strong>, J.N. D1 <strong>and</strong> D2 dopamine receptors do not up-regulate inresponse to neonatal intrastriatal 6-hydroxydopamine lesions. Neurosci. Lett. 160:77-80,1993.63. Frohna, P.A., Neal-Beliveu, B.S. <strong>and</strong> <strong>Joyce</strong>, J.N. Neonatal 6-OHDA lesions upregulateadult expression <strong>of</strong> tyrosine hydroxylase mRNA. NeuroReport 4: 1095-1098, 1993.64. Neal-Beliveau, B.S., <strong>Joyce</strong>, J.N., <strong>and</strong> Lucki, I. Serotonergic involvement in haloperidolinducedcatalepsy. J. Pharmacol. Expt. Therap. 265: 207-217, 1993.65. <strong>Joyce</strong>, J.N., Kaeger, C, Ryoo, H <strong>and</strong> Goldsmith, S.: Dopamine D2 receptors in thehippocampus <strong>and</strong> amygdala in Alzheimer’s disease. Neurosci. Lett..154:171-174, 1993.66. <strong>Joyce</strong>, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M. F., <strong>and</strong> Kleinman, J. E.:Serotonin uptake sites <strong>and</strong> serotonin receptors are altered in limbic system <strong>of</strong>schizophrenics. Neuropsychopharmacol. 8:315-336, 1993.67. <strong>Joyce</strong>, J.N. Differential response <strong>of</strong> striatal dopamine receptor subtypes <strong>and</strong> cholinergic14
Change language